AI Article Synopsis
Article Abstract
Seven patients had occlusive stomahesive dressings placed on their tracheostomies. These patients were compared with four patients managed with standard tracheostomy care. Stomahesive was applied using a defined technique and all seven patients were followed until tracheostomy closure. The average duration of stomahesive care was 26 days and the dressings remained occlusive for an average of 4 days. Photographic evidence revealed that skin changes were less in patients treated with stomahesive dressings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0300-9572(83)90006-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Solution using Stomahesive® wafers for allergic contact dermatitis caused by isobornyl acrylate in glucose monitoring sensors.
Australas J Dermatol
February 2022
Skin Health Institute, Carlton, Victoria, Australia.
Isobornyl acrylate (IBOA) has recently caused a number of cases of allergic contact dermatitis (ACD) from its use in medical devices. We would like to enhance the awareness of this issue with the reporting of three Australian cases, involving two adults and a child. We also report a successful solution by using hydrocolloid wafer (Stomahesive®) as a barrier.
View Article and Find Full Text PDFUsage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems.
J Diabetes Sci Technol
May 2020
Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Germany.
Background: Continuous glucose monitoring (CGM) systems replace more and more capillary self-monitoring of blood glucose by patients with diabetes. However, at least a subset of patients experience adverse skin reactions such as severe allergic contact dermatitis (ACD) after prolonged usage of CGM systems. A major allergen isobornyl acrylate (IBOA) has been identified recently.
View Article and Find Full Text PDFUsing wound bed preparation to heal a malignant fungating wound: a single case study.
J Wound Care
October 2007
Department of Nursing, Tzu Chi College of Technology, Taiwan.
Full healing was achieved within eight weeks in a malignant fungating wound using the principles of the TIME paradigm. This concept appears to provide a structured and systematic approach for managing such non-healing wounds.
View Article and Find Full Text PDFEfficacy of a skin-protection powder for use as a dressing for intractable ulcers.
J Wound Care
November 2006
Department of Plastic, Reconstructive and Aesthetic Surgery, Burn Care Unit, Kyorin University School of Medicine,Tokyo, Japan.
Objective: Stomahesive skin-protection powder has been reported to be useful as a skin-care and skin-barrier product for the management of stomas. This study aimed to evaluate its efficacy, in terms of wound healing, moisture retention and pain management, as an alternative to conventional dressing materials. Both clinical and animal studies were undertaken.
View Article and Find Full Text PDFAnalgesic effects of topical methadone: a report of four cases.
Clin J Pain
April 2005
Division of Palliative Care and Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada.
Topical morphine has been used on open wounds for pain management, but has a variable duration of action not suitable for palliative dressing changes. The objective of this study is to find an opioid and delivery method that would provide long-lasting pain relief between dressing changes. Methadone powder (100 mg) was mixed in Stomahesive powder (10 g) and sprinkled on the open wound once daily at the time of dressing change.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!